8 studies found for:    "GLUT1 deficiency syndrome"
Show Display Options
Rank Status Study
1 Recruiting Phase 2 Study of Triheptanoin (UX007) for the Treatment of Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)
Condition: Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)
Interventions: Drug: UX007 (triheptanoin);   Drug: Placebo Oil
2 Recruiting An Open-Label Trial of Triheptanoin in Patients With Glucose Transporter Type-1 Deficiency Syndrome
Condition: Glucose Transporter Type-1 Deficiency Syndrome (Glut1 DS)
Intervention: Drug: Triheptanoin
3 Recruiting The Glucose Transporter Type I Deficiency (G1D) Registry
Conditions: GLUT1 Deficiency Syndrome;   Glucose Transporter Type 1 Deficiency Syndrome;   Glucose Transporter type1 (GLUT-1) Deficiency;   GLUT-1 Deficiency Syndrome
Intervention: Other: No intervention
4 Available Post Study Continuation of C7 for G1D
Conditions: Glut1 Deficiency Syndrome;   Glucose Transporter Type 1 Deficiency Syndrome
Intervention: Drug: Triheptanoin
5 Active, not recruiting Treatment Development for Glucose Transporter Type I Deficiency Syndrome (G1D)
Conditions: Glucose Transporter Type 1 Deficiency Syndrome;   GLUT1 Deficiency Syndrome
Intervention: Drug: Triheptanoin
6 Not yet recruiting Triheptanoin (C7 Oil), a Food Supplement, for Glucose Transporter Type I Deficiency (G1D)
Conditions: Glucose Transporter Type 1 Deficiency Syndrome;   Glut1 Deficiency Syndrome
Intervention: Drug: Triheptanoin
7 Recruiting Phase II Open Label Study Using Triheptanoin in Patients With Glucose Type 1 Transporter Deficiency GLUT1-DS
Condition: Glut1 Deficiency Syndrome
Intervention: Drug: GLUT1 DS
8 Not yet recruiting Pilot Study of Triheptanoin in Patients With Glucose Transporter 1 Deficiency Syndrome
Condition: Glucose Transporter Type 1 Deficiency Syndrome
Intervention: Drug: Triheptanoin

Indicates status has not been verified in more than two years